Bristol-Myers Squibb (NYSE:BMY) Q3 2026 Earnings Call
Bristol-Myers Squibb (NYSE:BMY) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Bristol-Myers Squibb Company (NYSE:BMY)
- Period
- Q3 2026 earnings call
- Date
- Thu, Oct 29, 2026, 8:00 AM ET
On 6ix: 6ix.com/event/bristol-myers-squibb-company-bmy-q3-2026-earnings-call
Latest news releases
- NYSE:BMY — Bristol Myers Squibb Presents Results from Phase 1 Breakfree-2 Study of Zolacabtagene Autoleucel (BMS-986353) in Patients with Highly Active Relapsing and Progressive Forms of Multiple… · Fri, Oct 23, 2026
- NYSE:BMY — Izalontamab Brengitecan (Iza-Bren) Reduced Risk of Disease Progression or Death by 59% versus Chemotherapy in Patients with Advanced HR+/HER2- Breast Cancer in Phase 3 PANKU-Breast01 Study · Fri, Oct 23, 2026